ANDA 80883, held by Lilly. Vitamin A Palmitate.
As of Nov 16, 2026, ANDA 80883 (Alphalin), held by Lilly, was first approved by FDA on Jul 18, 1973, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 18, 1973 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| AlphalinEQ 50,000 UNITS BASE ยท capsule;oral | Vitamin A Palmitate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters